BP100 [Y10Q]
General Information
DRACP ID DRACP00703
Peptide Name BP100 [Y10Q]
Sequence KKLFKKILKQL
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=53.6±4.2µM | MTT assay | 48h | 1 |
MCF-7/ADM | Invasive breast carcinoma of no special type | Carcinoma | IC50=53.3±4.5µM | MTT assay | 48h | 1 |
K562 | Blast phase chronic myelogenous leukemia, BCR-ABL22 positive; Chronic myeloid leukemia | Leukemia | IC50=57.6±3.9µM | MTT assay | 48h | 1 |
K562/ADM | Blast phase chronic myelogenous leukemia, BCR-ABL23 positive; Chronic myeloid leukemia | Leukemia | IC50=58.3±6.2µM | MTT assay | 48h | 1 |
Hemolytic Activity Rabbit erythrocytes: 6.5% Hemolysis=160µM
Normal (non-cancerous) Cytotoxicity GES-1: IC50=77.9±5.6µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C68H123N17O13
Absent amino acids ACDEGHMNPRSTVWY
Common amino acids K
Mass 156539
Pl 11.4
Basic residues 5
Acidic residues 0
Hydrophobic residues 5
Net charge 5
Boman Index -1063
Hydrophobicity -39.09
Aliphatic Index 141.82
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 28474125
Title Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities
Year 2017
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available